TREM2 protects against LPS-induced murine acute lung injury through suppressing macrophage ferroptosis
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114247 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Dandan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Membrane Glycoproteins, Ferroptosis, Macrophages. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Henan Province Natural Science Foundation, Henan Medical Science and Technique Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Triggering receptor expressed on myeloid cells-2 (TREM2) is a cell surface receptor, majorly expressed by granulocytes, monocytes and macrophages. We in this study showed that TREM2 was downregulated in the lipopolysaccharide (LPS)-treated macrophages and murine acute lung injury (ALI) through activation of p38 MAPK and STAT6 signaling. Over-expression of TREM2 reduced the expression of DNAX-activation protein 12 (DAP12), pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), Malondialdehyde (MDA) and hemosiderin accumulation in LPS-treated macrophages. Knockdown of TREM2 expression elevated the expression of IL-6, reactive oxygen species (ROS), lactate dehydrogenases (LDH) and hemosiderin accumulation. Intratracheal adoptive transfer of TREM2-overexpressing macrophages effectively suppressed the lung inflammation and pro-inflammatory cytokine expression in murine ALI. While downregulation of TREM2 enhanced the lung inflammation in the lung tissues of murine ALI. Therefore, TREM2/DAP12 axis is involved in macrophage ferroptosis and attenuation of murine ALI. TREM2 would be a novel therapeutic target in murine ALI and patients with acute respiratory distress syndrome (ARDS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Pulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China.
- Department of Pulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China. Electronic address: jiang.zhilong@zs-hospital.sh.cn.
Förderung
- Henan Province Natural Science Foundation
- Henan Medical Science and Technique Foundation
- National Natural Science Foundation of China
Zitieren
APA
Li, D., Pan, L., Chen, M., Zhang, X., & Jiang, Z. (2025). TREM2 protects against LPS-induced murine acute lung injury through suppressing macrophage ferroptosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114247
Vancouver
Li D, Pan L, Chen M, Zhang X, Jiang Z. TREM2 protects against LPS-induced murine acute lung injury through suppressing macrophage ferroptosis. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114247
BibTeX
@article{Li2025,
author = {Li, Dandan and Pan, Linyue and Chen, Mengjie and Zhang, Xiaoju and Jiang, Zhilong},
title = {TREM2 protects against LPS-induced murine acute lung injury through suppressing macrophage ferroptosis},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114247}
}
EUVIMED